Publication | Open Access
PODO: Trial Design: Phase 2 Study of PF-06730512 in Focal Segmental Glomerulosclerosis
16
Citations
6
References
2021
Year
Findings from this proof-of-concept study may support further development and evaluation of PF-06730512 to treat FSGS and warrant assessment in phase 3 clinical trials.
| Year | Citations | |
|---|---|---|
Page 1
Page 1